SI1791571T1 - Radiofluorirani peptidi - Google Patents

Radiofluorirani peptidi

Info

Publication number
SI1791571T1
SI1791571T1 SI200530442T SI200530442T SI1791571T1 SI 1791571 T1 SI1791571 T1 SI 1791571T1 SI 200530442 T SI200530442 T SI 200530442T SI 200530442 T SI200530442 T SI 200530442T SI 1791571 T1 SI1791571 T1 SI 1791571T1
Authority
SI
Slovenia
Prior art keywords
radiofluorinated
peptides
processes
radiopharmaceuticals
iiia
Prior art date
Application number
SI200530442T
Other languages
English (en)
Inventor
Magne Solbakken
Bente Arbo
Alan Cuthbertson
Alexander Gibson
Original Assignee
Ge Healthcare As
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As, Ge Healthcare Ltd filed Critical Ge Healthcare As
Publication of SI1791571T1 publication Critical patent/SI1791571T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200530442T 2004-09-14 2005-09-14 Radiofluorirani peptidi SI1791571T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds
EP05790076A EP1791571B1 (en) 2004-09-14 2005-09-14 Radiofluorinated peptides

Publications (1)

Publication Number Publication Date
SI1791571T1 true SI1791571T1 (sl) 2009-02-28

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530442T SI1791571T1 (sl) 2004-09-14 2005-09-14 Radiofluorirani peptidi

Country Status (24)

Country Link
US (2) US7875701B2 (sl)
EP (1) EP1791571B1 (sl)
JP (1) JP4949251B2 (sl)
KR (1) KR101243016B1 (sl)
CN (1) CN101151054B (sl)
AT (1) ATE404225T1 (sl)
AU (1) AU2005283904B8 (sl)
BR (1) BRPI0515175A (sl)
CA (1) CA2578470C (sl)
DE (1) DE602005008996D1 (sl)
DK (1) DK1791571T3 (sl)
ES (1) ES2312018T3 (sl)
GB (1) GB0420344D0 (sl)
HK (1) HK1118713A1 (sl)
IL (1) IL181529A (sl)
MX (1) MX2007003019A (sl)
NO (1) NO20071880L (sl)
NZ (1) NZ553384A (sl)
PL (1) PL1791571T3 (sl)
PT (1) PT1791571E (sl)
RU (1) RU2396272C9 (sl)
SI (1) SI1791571T1 (sl)
WO (1) WO2006030291A2 (sl)
ZA (1) ZA200702700B (sl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
EP1985624A3 (en) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Single step method of radiofluorination of biologically active compounds or biomolecules
JP5237283B2 (ja) 2006-09-15 2013-07-17 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド インテグリンのためのイメージング剤としてのシクロペプチド誘導体
US8247534B2 (en) 2006-12-13 2012-08-21 Ge Healthcare As Synthesis of radiofluorinated peptide using microwave activation technology
WO2008075966A2 (en) * 2006-12-18 2008-06-26 Ge Healthcare As Synthesis of a radiofluorinated peptide using photolabile protecting groups
EP2114464A2 (en) * 2006-12-28 2009-11-11 GE Healthcare AS Radiofluorination methods
EP2146753A2 (en) * 2007-03-01 2010-01-27 Bayer Schering Pharma Aktiengesellschaft 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof
US8444955B2 (en) 2007-09-10 2013-05-21 Ge Healthcare Limited Radiofluorination methods
JP5399422B2 (ja) * 2008-02-28 2014-01-29 ジーイー・ヘルスケア・リミテッド 市販の安価な化学薬品からのｐｅｇ−６成分の合成
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
WO2011084763A1 (en) 2009-12-21 2011-07-14 Ge Healthcare Limited Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
ES2929507T3 (es) 2010-12-01 2022-11-29 Ge Healthcare Ltd Método para marcar una molécula directora biológica mediante conjugación con un radioisótopo adecuado para formación de imágenes por PET o SPECT
CA2820387A1 (en) * 2010-12-09 2012-06-14 Ge Healthcare Limited Radiotracer compositions
CA2822583A1 (en) 2010-12-21 2012-06-28 Ge Healthcare Limited Use of aniline in the radiostabilization of oxime ligation reactions
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
CN106999603B (zh) 2014-12-04 2022-05-27 通用电气健康护理有限公司 从放射性药物中除去乙醛的方法
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
CA2578470A1 (en) 2006-03-23
US20110117016A1 (en) 2011-05-19
PL1791571T3 (pl) 2009-01-30
NZ553384A (en) 2011-02-25
ES2312018T3 (es) 2009-02-16
BRPI0515175A (pt) 2008-07-08
PT1791571E (pt) 2008-11-19
WO2006030291A3 (en) 2007-06-14
ATE404225T1 (de) 2008-08-15
ZA200702700B (en) 2008-09-25
US7875701B2 (en) 2011-01-25
DE602005008996D1 (de) 2008-09-25
WO2006030291A2 (en) 2006-03-23
CN101151054B (zh) 2014-09-24
RU2007108762A (ru) 2008-10-27
RU2396272C9 (ru) 2010-12-10
JP2008516894A (ja) 2008-05-22
KR101243016B1 (ko) 2013-03-12
DK1791571T3 (da) 2008-12-08
US20080095701A1 (en) 2008-04-24
AU2005283904B8 (en) 2012-02-23
NO20071880L (no) 2007-06-13
AU2005283904A1 (en) 2006-03-23
HK1118713A1 (en) 2009-02-20
US8563600B2 (en) 2013-10-22
AU2005283904B2 (en) 2012-01-19
GB0420344D0 (en) 2004-10-13
EP1791571A2 (en) 2007-06-06
MX2007003019A (es) 2007-08-07
RU2396272C2 (ru) 2010-08-10
CA2578470C (en) 2015-09-01
JP4949251B2 (ja) 2012-06-06
IL181529A0 (en) 2007-07-04
CN101151054A (zh) 2008-03-26
EP1791571B1 (en) 2008-08-13
KR20070053750A (ko) 2007-05-25
IL181529A (en) 2015-04-30

Similar Documents

Publication Publication Date Title
SI1791571T1 (sl) Radiofluorirani peptidi
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MXPA05009682A (es) Metodos de radiofluorinacion de vectores biologicamente activos.
TN2010000213A1 (en) Wise binding antibodies and epitopes
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
IL220412A0 (en) Antibodies which bind to gm-csf, polynucleotides encoding the same, pharmaceutical compositions containing the same and uses thereof
TW200505875A (en) Novel compounds
NZ612161A (en) Radiolabled her2 binding peptides
NO20092611L (no) Krystallinsk faststoff Rasagilin base
IL191655A0 (en) Novel compounds, their preparation and use
TW200800967A (en) Benzimidazole thiophene compounds
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
TW200736227A (en) New compounds III
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
TW200738649A (en) Calcilytic compounds
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
WO2009035959A3 (en) Radiofluorination methods
TW200745133A (en) New compounds II
GB0615105D0 (en) Novel compounds
WO2008083191A3 (en) Radiofluorination methods
TW200633717A (en) Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
EA200870565A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение
EA200870566A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензотиазепины, их получение, композиции, содержащие их, и применение